New information about hormone therapy and cardiovascular disease prevention in women.
Goldie
Maria Perno
MP
mgoldie@sbcglobal.net
D000328:Adult; D000367:Age Factors; D000368:Aged; D000572:American Heart Association; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000517:prevention & control*; D004338:Drug Combinations; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004967:Estrogens / Q000009:adverse effects; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects; D005260:Female; D017408:Guidelines as Topic; D006801:Humans; D008019:Life Style; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects; D008875:Middle Aged; D012307:Risk Factors; D014481:United States
D004338:Drug Combinations; D004967:Estrogens; D004966:Estrogens, Conjugated (USP); C466383:Prempro; D017258:Medroxyprogesterone Acetate